Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Here we report an increased prevalence of vitamin D (VitD) deficiency in patients diagnosed with opioid use disorder and an inverse and dose-dependent association of VitD levels with self-reported opioid use.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vdr−/− mice were provided by M.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D deficiency exacerbates UV/endorphin and opioid addiction

Study design awaiting verification · Science Advances · 2021

Original publication title

Vitamin D deficiency exacerbates UV/endorphin and opioid addiction

Lajos V. Kemény; Kathleen C. Robinson; Andrea L. Hermann; Deena M. Walker; Susan Regan; Yik Weng Yew; Yi Chun Lai; Nicholas Theodosakis; Phillip D. Rivera; Weihua Ding; Liuyue Yang; Tobias Beyer; Yong-Hwee E. Loh; Jennifer A. Lo; Anita A. J. van der Sande; William Sarnie; David Kotler; Jennifer J. Hsiao; Mack Y. Su; Shinichiro Kato; Joseph Kotler; Staci D. Bilbo; Vanita Chopra; Matthew P. Salomon; Shiqian Shen; Dave S. B. Hoon; Maryam M. Asgari; Sarah E. Wakeman; Eric J. Nestler; David E. Fisher

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Addiction to UV light and opioids is increased by VitD deficiency, suggesting that a feedback loop promotes its synthesis.

The current opioid epidemic warrants a better understanding of genetic and environmental factors that contribute to opioid addiction. Here we report an increased prevalence of vitamin D (VitD) deficiency in patients diagnosed with opioid use disorder and an inverse and dose-dependent association of VitD levels with self-reported opioid use. We used multiple pharmacologic approaches and genetic mouse models and found that deficiencies in VitD signaling amplify exogenous opioid responses that are normalized upon restoration of VitD signaling. Similarly, physiologic endogenous opioid analgesia and reward responses triggered by ultraviolet (UV) radiation are repressed by VitD signaling, suggesting that a feedback loop exists whereby VitD deficiency produces increased UV/endorphin-seeking behavior until VitD levels are restored by cutaneous VitD synthesis.

This feedback may carry the evolutionary advantage of maximizing VitD synthesis. However, unlike UV exposure, exogenous opioid use is not followed by VitD synthesis (and its opioid suppressive effects), contributing to maladaptive addictive behavior.

Authors’ abstract

Addiction to UV light and opioids is increased by VitD deficiency, suggesting that a feedback loop promotes its synthesis.

The current opioid epidemic warrants a better understanding of genetic and environmental factors that contribute to opioid addiction. Here we report an increased prevalence of vitamin D (VitD) deficiency in patients diagnosed with opioid use disorder and an inverse and dose-dependent association of VitD levels with self-reported opioid use. We used multiple pharmacologic approaches and genetic mouse models and found that deficiencies in VitD signaling amplify exogenous opioid responses that are normalized upon restoration of VitD signaling. Similarly, physiologic endogenous opioid analgesia and reward responses triggered by ultraviolet (UV) radiation are repressed by VitD signaling, suggesting that a feedback loop exists whereby VitD deficiency produces increased UV/endorphin-seeking behavior until VitD levels are restored by cutaneous VitD synthesis.

This feedback may carry the evolutionary advantage of maximizing VitD synthesis. However, unlike UV exposure, exogenous opioid use is not followed by VitD synthesis (and its opioid suppressive effects), contributing to maladaptive addictive behavior.

Publication and source details

Original title: Vitamin D deficiency exacerbates UV/endorphin and opioid addiction

Lajos V. Kemény; Kathleen C. Robinson; Andrea L. Hermann; Deena M. Walker; Susan Regan; Yik Weng Yew; Yi Chun Lai; Nicholas Theodosakis; Phillip D. Rivera; Weihua Ding; Liuyue Yang; Tobias Beyer; Yong-Hwee E. Loh; Jennifer A. Lo; Anita A. J. van der Sande; William Sarnie; David Kotler; Jennifer J. Hsiao; Mack Y. Su; Shinichiro Kato; Joseph Kotler; Staci D. Bilbo; Vanita Chopra; Matthew P. Salomon; Shiqian Shen; Dave S. B. Hoon; Maryam M. Asgari; Sarah E. Wakeman; Eric J. Nestler; David E. Fisher

Science Advances · 2021

* Corresponding author. Email: dfisher3@mgh.harvard.edu
†

These authors contributed equally to this work.

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).2021The Authorshttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.http://dx.doi.org/10.13039/100000002National Institutes of Health5R01 722http://dx.doi.org/10.13039/100000002National Institutes of HealthAR043369-21http://dx.doi.org/10.13039/100000002National Institutes of Health5R01 AR043369-21http://dx.doi.org/10.13039/100000069National Institute of Arthritis and Musculoskeletal and Skin Diseases5R01 AR043369-21http://dx.doi.org/10.13039/100005930ASCRS Research Foundationhttp://dx.doi.org/10.13039/100005984Dr. Miriam and Sheldon G. Adelson Medical Research Foundationhttp://dx.doi.org/10.13039/100012505Royal Perth Hospital Medical Research Foundationhttp://dx.doi.org/10.13039/501100015269Magyarország Kormánya

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:37:34.828205+00:00

DOI: 10.1126/sciadv.abe4577 · PMC8195487